Este sitio web utilitza cookies para mejorar su experiencia. Si continua navegando, consideramos que Acepta su uso. Más información
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
In a statement on Thursday, the foreign ministry explained the move, saying it had received the request for authorisation on 24 February.
The move has been backed by the European Commission, reports say.
The decision affects 250,000 doses of the vaccine produced at an AstraZeneca facility in Italy.